Wells Fargo & Company Rockwell Medical, Inc. Transaction History
Wells Fargo & Company
- $429 Billion
- Q1 2025
A detailed history of Wells Fargo & Company transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 3,574 shares of RMTI stock, worth $3,895. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,574
Previous 3,574
-0.0%
Holding current value
$3,895
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RMTI
# of Institutions
53Shares Held
7.13MCall Options Held
92.8KPut Options Held
14.9K-
Armistice Capital, LLC New York, NY2.37MShares$2.58 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.21MShares$1.31 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$810,1490.08% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny453KShares$493,7710.0% of portfolio
-
Marshall Wace, LLP London, X0334KShares$363,6180.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $11.6M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...